Negative Pressure Wound Therapy Devices Market Size, Share & Trends Analysis Report By Product (Conventional NPWT Devices, Portable/Disposable NPWT, NPWT Accessories), By Wound Type (Acute Wound, Chronic Wound), By End Use (Hospitals, Specialty Clinics, Home Healthcare, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Negative Pressure Wound Therapy Devices Market Size

The global negative pressure wound therapy devices market size was valued at USD 2.63 billion in 2025 and is projected to grow from USD 2.80 billion in 2026 to USD 4.58 billion by 2034, registering a CAGR of 6.35% during the forecast period from 2026 to 2034. North America dominated the negative pressure wound therapy devices market with a market share of 45.18% in 2025.

Product Insights

NPWT accessories held a dominant share of 38.99% in 2025, due to their recurring utilization of dressings canisters, tubing kits, and wound interface components across prolonged therapy durations. They also need to be replaced after every therapy session, which leads to high recurring demand. Repeat purchases can also be attributed to growing innovations in accessories such as improved seals and antimicrobial dressings, which increase clinicians’ trust.

The portable and disposable NPWT systems segment is expected to register a 7.22% CAGR during the forecast period. Healthcare providers increasingly adopt compact, single patient use devices that support therapy continuation beyond inpatient care. Portable and disposable NPWT systems are user-friendly, lightweight, and ready-to-use products, which drives their adoption in home-based and outpatient care facilities.

Request Customizationto receive a tailored report.

Wound Type Insights

Chronic wounds accounted for a dominant share of the wound type segment in 2025. NPWT products are used more in chronic wounds due to long healing timelines associated with diabetic foot ulcers, pressure ulcers, and venous leg ulcers. Extended therapy duration, combined with high recurrence rates, drives sustained NPWT utilization across chronic care and long-term wound management programs.

The acute wounds segment is expected to grow at a CAGR of 7.56%, as NPWT adoption expands across surgical incisions, traumatic injuries, and burn management. Increasing use of NPWT for incision management and post-operative wound stabilization supports accelerated adoption in acute care and surgical recovery protocols.

End Use Insights

Hospitals led the end-use segment with a 43.77% share in 2025 due to high volumes of surgical procedures, trauma admissions, and chronic wound cases requiring supervised NPWT applications. Standard clinical protocols in hospitals have already integrated NPWT procedures, as seen in surgical wards, ICUs, and trauma centers. NPWT systems are deployed more safely in these facilities backed by healthcare professionals and advanced infrastructure. These factors are expected to propel the negative pressure wound therapy devices market growth in the hospitals segment.

The home healthcare segment is expected to grow at a CAGR of 7.12%, driven by increased transition of wound management from hospitals to domiciliary care environments. High adoption of portable NPWT systems, combined with structured home-based wound monitoring, supports rising utilization across post-discharge and long-duration therapy scenarios.

Speak to an Analystto discuss market opportunities.

Regional Analysis

The negative pressure wound therapy devices market in North America held the largest share of 45.18% in 2025. This dominance is driven by advanced surgical wound management and structured chronic wound care programs across hospitals in this region. Clinical guidelines across the region increasingly integrate NPWT for surgical incisions, diabetic foot ulcers, and pressure injuries as part of standardized inpatient and post-discharge care pathways.

The US dominates the regional market, supported by domestic NPWT manufacturing and large-scale hospital procurement. For instance, 3M continues broad deployment of V.A.C. Therapy systems across US hospitals and integrated delivery networks for surgical and chronic wound management. Smith+Nephew distributes PICO single-use NPWT systems across US surgical centers for closed incision management following orthopedic and abdominal procedures. NPWT products, such as XLR8+, Extremity i-VAC, and RENASYS Touch, are produced by US companies such as Genadyne Biotechnologies, Devon Medical, and Smith+Nephew, respectively. These factors are expected to propel the US negative pressure wound therapy market growth during the forecast period.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific

The Asia Pacific negative pressure wound therapy devices market is projected to record the fastest growth of 8.35% during the forecast period, driven by the increasing burden of diabetic ulcers, traumatic injuries, and post-surgical wound complications. Public hospitals across the region expand advanced wound care capabilities as part of tertiary care strengthening programs, which support NPWT adoption in urban medical centers. Government healthcare initiatives increasingly emphasize early wound closure and infection control to reduce long-term treatment costs.

China remains a key contributor in the Asia Pacific, supported by large-scale hospital expansion and domestic production of wound care devices. Regulatory announcements from the National Medical Products Administration indicate rising approvals for domestically manufactured NPWT systems for hospital use.

Europe

The European NPWT devices market is supported by structured postoperative recovery protocols and national strategies addressing chronic wound prevalence among aging populations. Hospitals across the region integrate NPWT into orthopedic vascular and abdominal surgery pathways to manage exudate and reduce wound-related complications. National health services promote standardized wound care assessment, which sustains consistent NPWT utilization within public healthcare systems.

Germany is expected to hold a major share of the Europe negative pressure wound therapy devices due to established wound care specialization and favorable government support. The German Federal Ministry of Health identifies chronic wound treatment as a priority area within inpatient care. Companies such as Mölnlycke reported continued supply of Avance NPWT systems to German hospitals through public healthcare procurement frameworks, supporting surgical and chronic wound management.

Middle East and Africa

The Middle East and Africa negative pressure wound therapy devices market is shaped by expanding public hospital infrastructure and growing focus on advanced wound care within government-funded healthcare systems. National health strategies prioritize management of diabetic foot ulcers surgical wounds and trauma-related injuries, which supports gradual NPWT integration into hospital formularies. Training initiatives for wound care clinicians further support adoption across tertiary hospitals.

Saudi Arabia leads regional utilization of NPWT systems through centralized healthcare planning and hospital modernization programs. The Saudi Ministry of Health focuses on procuring advanced wound care technologies, including NPWT, within public hospitals and specialty care centers. For instance, Smith+Nephew supplies NPWT systems to government hospitals as part of surgical site management initiatives aligned with national healthcare transformation goals.

Latin America

The Latin America negative pressure wound therapy devices market demonstrates steady expansion, driven by public healthcare investment targeting chronic wound management and postoperative recovery. National health authorities increasingly recognize diabetic foot ulcers and pressure injuries as drivers of long-term hospitalization, which supports adoption of NPWT within tertiary care hospitals. Public procurement systems influence NPWT placement across large hospital networks, which propels market growth.

Brazil dominates the regional market due to its unified health system (SUS) and private-public partnerships. SUS covers chronic disease management and outpatient care, which creates consistent institutionalized demand for advanced wound therapies. Key players, such as Convatec, reported the expanded supply of NPWT systems to Brazilian public healthcare facilities, supporting chronic wound and surgical wound management programs.

Competitive Landscape

The negative pressure wound therapy devices market is moderately concentrated and features a mix of established wound care manufacturers and emerging players focused on portable and disposable therapy solutions. Market competition is shaped by parameters such as therapy delivery, conventional vs. portable systems, applicability across acute and chronic wound types, and suitability for hospital outpatient and home healthcare settings. Leading companies sustain their market position through broad NPWT portfolios encompassing pumps dressings and accessories supported by clinical usage data and long-term supply agreements with hospitals and integrated care networks.

List of Key and Emerging Players in Negative Pressure Wound Therapy Devices Market